Geode Capital Management’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $72.4K | Hold |
|
|||||
|
2025
Q2 | $98.5K | Sell |
|
|||||
|
2025
Q1 | $128K | Buy |
|
|||||
|
2024
Q4 | $183K | Buy |
|
|||||
|
2024
Q3 | $198K | Buy |
|
|||||
|
2024
Q2 | $209K | Buy |
|
|||||
|
2024
Q1 | $2.24M | Buy |
|
|||||
|
2023
Q4 | $1.76M | Buy |
|
|||||
|
2023
Q3 | $1.21M | Buy |
|
|||||
|
2023
Q2 | $612K | Hold |
|
|||||
|
2023
Q1 | $308K | Hold |
|
|||||
|
2022
Q4 | $467K | Buy |
|
|||||
|
2022
Q3 | $735K | Buy |
|
|||||
|
2022
Q2 | $680K | Buy |
|
|||||
|
2022
Q1 | $150K | Buy |
|
|||||
|
2021
Q4 | $157K | Hold |
|
|||||
|
2021
Q3 | $329K | Sell |
|
|||||
|
2021
Q2 | $289K | Sell |
|
|||||
|
2021
Q1 | $1.05M | Buy |
|
|||||
|
2020
Q4 | $781K | Buy |
|
|||||
|
2020
Q3 | $452K | Buy |
|
|||||
|
2020
Q2 | $375K | Buy |
|